<DOC>
	<DOC>NCT01907958</DOC>
	<brief_summary>Multicenter stepped wedge cluster randomized trial of family practice clinics in Quebec and Ontario comparing the effect of introducing a Point of Care testing (POCT) for urine albumin to usual practice on quality of care in hypertensive patients with Type 2 diabetes.</brief_summary>
	<brief_title>Management of Albuminuria in Hypertensive Diabetics</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Albuminuria</mesh_term>
	<criteria>Male or female 18 years and older and able to visit the study sites every 3 months T2D patients with ongoing antidiabetic therapy for at least 5 years Uncontrolled hypertension according to 2012 CHEP recommendations for management of hypertension in diabetic patients ( i.e. BP&gt; 130/80 mmHg) Able and agreeing to provide informed consent. Type 1 diabetes patients Ongoing therapy with perindopril, Known hypersensitivity or allergies to ACEI or sulfonamide derivatives, A history of angioedema related or not to previous treatment with ACEI, Impaired renal function defined as serum creatinine levels &gt; 177 Âµmol/L, eGFR &lt;30 mL/min, Hyperkalemia or hypokalemia, Severe hepatic impairment, Use of nonantiarrhythmic agents causing torsade de pointes, Pregnant or lactating women, or who are planning to become pregnant, Any conditions which may impact on participation according to treating physician.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Microalbuminuria</keyword>
	<keyword>Hypertensive</keyword>
	<keyword>Diabetics</keyword>
	<keyword>urine albumin</keyword>
</DOC>